Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

P-cadherin is crucial for hair follicle pigmentation but not skin pigmentation.

Changes in the SREBF1 gene cause a rare genetic skin and hair disorder.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

A cluster of sulfur-rich hair protein genes was found on chromosome 17.

AR polyglycine repeat doesn't cause baldness.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Hair loss in certain mice is linked to changes in keratin-related genes.

CRABP2 helps increase the growth of cells important for hair growth by activating a specific growth pathway.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Four genetic risk areas related to male-pattern baldness were identified, with WNT signaling playing a role in its development.

Mother and son diagnosed with a rare genetic hair loss condition with no effective treatment.

Men with male pattern baldness have a higher risk of aggressive prostate cancer and benign prostatic hyperplasia.

Early baldness in men may indicate a higher risk of prostate cancer.

Scientists found gene mutations that affect hair loss, skin stem cells, and skin disorders, and identified drugs that may help treat blood vessel and skin conditions.

Researchers found a new area on chromosome 2 linked to a genetic hair loss condition.

Certain gene variations in EGF and EGFR may increase the risk of alopecia areata in Koreans.

Basal cell carcinomas need extra mutations to grow from small to large tumors.

A new mutation in mice causes crooked whiskers and messy hair.

The hairless gene mutation causes baldness by disrupting hair follicle structure.

A Jordanian family with Clouston syndrome has a common GJB6 gene mutation.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

A specific gene mutation causes monilethrix in this family, and minoxidil treatment improves hair condition.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

The mutation causing Hutchinson-Gilford progeria syndrome leads to severe skin problems and early death in mice.